ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.
This study has been completed.
Study NCT00077636.
Last updated on May 13, 2009.
Information provided by Hoffmann-La Roche
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: